Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_65353
http://purl.obolibrary.org/obo/CHEBI_65353
|
|---|---|
| Preferred Name | lorcaserin |
| Synonyms |
C11H14ClN
(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
lorcaserin
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | lorcaserin
|
|---|---|
| label | lorcaserin
|
| DBSynonym |
apd356
apd-356
|
| Definition | Lorcaserin (previously APD-356), a highly selective 5HT2C receptor agonist, is used for the treatment of obesity. It has been shown to reduce body weight and food intake in animal models of obesity, and it is thought that targeting the 5HT2C receptor may alter body weight by regulating satiety. Lorcaserin is marketed as a salt form called Belviq, which is lorcaserin hydrochloride.
A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine substituted at position 1 by a methyl group and a t position 6 by a chloro group.
|
| DBSalt | lorcaserin hydrochloride
|
| type | |
| has role | |
| InChIKey | InChIKey=XTTZERNUQAFMOF-QMMMGPOBSA-N
|
| is metabolised by |
See more
See less
|
| Synonym |
C11H14ClN
(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
lorcaserin
|
| xref |
ChEBI:65350
ChEMBL:401194
Wikipedia:http://en.wikipedia.org/wiki/Lorcaserin
Reaxys:9904422
Drugs.com:http://www.drugs.com/mtm/lorcaserin.html
CASRN:616202-92-7
RxList:http://www.rxlist.com/belviq-drug.htm
See more
See less
|
| CASRN | 846589-98-8
|
| prefixIRI | obo2:CHEBI_65353
|
| related with | |
| SMILES | C[C@H]1CNCCc2ccc(Cl)cc12
|
| may interact with | |
| InChI | InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1
|
| DBBrand | belviq
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |